Literature DB >> 31492476

Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients.

E Celis-Rodríguez1, J C Díaz Cortés2, Y R Cárdenas Bolívar3, J A Carrizosa González4, D-I Pinilla5, L E Ferrer Záccaro6, C Birchenall7, J Caballero López8, B M Argüello9, G Castillo Abrego10, G Castorena Arellano11, C Dueñas Castell12, J M Jáuregui Solórzano13, R Leal14, J M Pardo Oviedo15, M Arroyo16, F Raffán-Sanabria17, N Raimondi18, R Reina19, D R Rodríguez Lima20, J I Silesky Jiménez21, S Ugarte Ubiergo22, L G Gómez Escobar23, D P Díaz Aya23, C Fowler24, J L Nates25.   

Abstract

Given the importance of the management of sedation, analgesia and delirium in Intensive Care Units, and in order to update the previously published guidelines, a new clinical practice guide is presented, addressing the most relevant management and intervention aspects based on the recent literature. A group of 24 intensivists from 9 countries of the Pan-American and Iberian Federation of Societies of Critical Medicine and Intensive Therapy met to develop the guidelines. Assessment of evidence quality and recommendations was made according to the Grading of Recommendations Assessment, Development and Evaluation Working Group. A systematic search of the literature was carried out using MEDLINE, Cochrane Library databases such as the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials (CENTRAL), the Database of Abstracts of Reviews of Effects, the National Health Service Economic Evaluation Database and the database of Latin American and Caribbean Literature in Health Sciences (LILACS). A total of 438 references were selected. After consensus, 47 strong recommendations with high and moderate quality evidence, 14 conditional recommendations with moderate quality evidence, and 65 conditional recommendations with low quality evidence were established. Finally, the importance of initial and multimodal pain management was underscored. Emphasis was placed on decreasing sedation levels and the use of deep sedation only in specific cases. The evidence and recommendations for the use of drugs such as dexmedetomidine, remifentanil, ketamine and others were incremented.
Copyright © 2019 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  ABCDEF; Agitación; Agitation; Analgesia; Clinical practice guidelines; Critical care; Cuidado intensivo; Delirium; Dolor; Guía de práctica clínica; Pain; Sedación; Sedation

Mesh:

Substances:

Year:  2019        PMID: 31492476     DOI: 10.1016/j.medin.2019.07.013

Source DB:  PubMed          Journal:  Med Intensiva (Engl Ed)        ISSN: 2173-5727


  6 in total

1.  Thiopental as substitute therapy for critically ill patients with COVID-19 requiring mechanical ventilation and prolonged sedation.

Authors:  V Jean-Michel; T Caulier; P-Y Delannoy; A Meybeck; H Georges
Journal:  Med Intensiva (Engl Ed)       Date:  2020-09-06

Review 2.  Sedation in the Intensive Care Unit.

Authors:  Valerie Page; Cathy McKenzie
Journal:  Curr Anesthesiol Rep       Date:  2021-04-24

3.  Thiopental as substitute therapy for critically ill patients with COVID-19 requiring mechanical ventilation and prolonged sedation.

Authors:  V Jean-Michel; T Caulier; P-Y Delannoy; A Meybeck; H Georges
Journal:  Med Intensiva (Engl Ed)       Date:  2022-01

4.  Safety and Efficacy of Sufentanil and Fentanyl Analgesia in Patients with Traumatic Brain Injury: A Retrospective Study.

Authors:  Wenhan Xia; Chunli Yang
Journal:  Med Sci Monit       Date:  2022-05-13

5.  Addition of Valerian and Lemon Balm Extract to Quetiapine Reduces Agitation in Critically Ill Patients with Delirium: A Pilot Randomized Clinical Trial.

Authors:  Babak Alikiaie; Erfan Shahmoradi; Afsaneh Yekdaneh; Sarah Mousavi
Journal:  Indian J Crit Care Med       Date:  2021-07

6.  Risk factors associated with the development of delirium in general ICU patients. A prospective observational study.

Authors:  Beatriz Lobo-Valbuena; Federico Gordo; Ana Abella; Sofía Garcia-Manzanedo; Maria-Mercedes Garcia-Arias; Inés Torrejón; David Varillas-Delgado; Rosario Molina
Journal:  PLoS One       Date:  2021-09-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.